Extending genetic vaccines with chemokines.
Kipps
T
T
Mendoza
R
R
D000970:Antineoplastic Agents / Q000276:immunology; D019496:Cancer Vaccines; D054410:Chemokine CCL7; D054357:Chemokine CXCL10; D018925:Chemokines / Q000627:therapeutic use*; D019743:Chemokines, CXC / Q000276:immunology; D016207:Cytokines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000627:therapeutic use*; D018448:Models, Immunological; D018945:Monocyte Chemoattractant Proteins / Q000276:immunology; D011744:Pyrimidinones; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects
D000970:Antineoplastic Agents; C515450:CCL7 protein, human; D019496:Cancer Vaccines; D054410:Chemokine CCL7; D054357:Chemokine CXCL10; D018925:Chemokines; D019743:Chemokines, CXC; D016207:Cytokines; D007135:Immunoglobulin Variable Region; D018945:Monocyte Chemoattractant Proteins; D011744:Pyrimidinones; D011993:Recombinant Fusion Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor